Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately
Lead Plaintiff Deadline is January 9, 2026 Wolf Haldenstein Adler Freeman & Herz LLPreminds purchasers or acquirers of Telix Pharmaceuticals Ltd. (NASDAQ: TLX)(“Telix) American Depositary Shares (“ADS”) between February 21, 2025 and August 28, 2025 (the “Class Period”) have until January 9, 2026 to seek appointment as lead plaintiff. https://mma.prnewswire.com/media/1064977/Wolf_Haldenstein_Adler_Freeman_Logo.jpg PLEASE CLICK HERE TO JOIN […]